Operation aims to strengthen the Company\'s financial position and maintain growth strategy SAO PAULO,May 24,2024-- Oncoclínicas&Co (B3: ONCO3),a leading oncology company headquartered in L
RIYADH,Saudi Arabia,May 24,2024--The shores of the Red Sea at the St. Regis Resort provided a stunning backdrop for the conclusion of the "Red Sea Fashion Week". Led by the Saudi Fashion Com
LONDON,May 23,2024-- Over the course of the flat panel display (FPD) industry\'s history,factory utilization has typically averaged approximately 84%. However,from 3Q22 to 4Q23,as theFPD market strug
PARIS,May 23,2024--GlocalMe®,the digital lifestyle brand under uCloudLink Group Inc. ("uCloudlink") (NASDAQ: UCL),today introduced three new products at VivaTech 2024. The GlocalMe Life
CS5001 is the first known ROR1 antibody-drug conjugate (ADC) to demonstrate clinical anti-tumor activity in both solid tumors and lymphomas,and among the top two globally in clinical development.
HoneyNaps secures $11.6 million in series B funding,propelling its entry into the American medical market.
